March 01, 2015 12:08 PM ET


Company Overview of OSI Pharmaceuticals Inc.

Executive Profile

Pierre Legault CA, MBA, CPA

Chief Executive Officer and Director, NephroGenex, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Pierre Legault, CA, MBA, CPA, has been the Chief Executive Officer of NephroGenex, Inc. since his joining in October 2013. Mr. Legault served as the Chief Financial Officer, Executive Vice President and Treasurer of OSI Pharmaceuticals Inc. since December 29, 2008 until January 2011 and served as its Principal Accounting Officer. He served as Chief Executive Officer of Prosidion, Ltd., a mid-size U.K. biotechnology firm. Mr. Legault served as the President US of ...

Corporate Headquarters

1 Bioscience Park Drive
Farmingdale, New York 11735

United States

Phone: 631-962-0600
Fax: 631-845-5671

Board Members Memberships

Former Executive Vice President and Member of Liaison & Strategic Planning Committee
Former Non-Executive Director and Chairman of the Audit Committee
Independent Director, Member of Audit Committee, Member of Compliance Committee and Member of Independent Committee
Chief Executive Officer and Director
Independent Director and Chairman of Audit Committee
Former Director


Unknown/Other Education
Harvard Business School
Bachelor's Degree
Ecole des Hautes Etudes Commerciales de Montreal
McGill University

Other Affiliations

Annual Compensation

Total Annual Compensation$289,516

Stocks Options

Restricted Stock Awards$496,080
All Other Compensation$3,098
Exercisable Options$66,545
Unexercisable Options$24,655
Total Number of Options$91,200

Total Compensation

Total Annual Cash Compensation$292,614
Total Short Term Compensation$289,516
Other Long Term Compensation$499,178
Total Calculated Compensation$914,690

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OSI Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at